Instem announces the closing of an acquisition of Xybion Digital (“Xybion”). Xybion is best known for its PristimaTM preclinical study management platform. Like Instem, Xybion has primarily focused on serving life sciences customers, particularly CROs, Pharmas, and Biotechnology firms. Xybion was founded in 1977 to support preclinical R&D and drug safety testing for regulatory submissions. In 2008, Banerjee Group LLC controlled by veteran life sciences R&D Executive and founding managing partner of Accenture’s life sciences R&D business, acquired Xybion and completed further acquisitions of Amadeus solutions, Stelex and Vital Path from GE Healthcare and Autoscribe Informatics.
Read the full article: Instem Achieves a Major Milestone, Acquires All Shares of Xybion from Banerjee Group LLC Controlled by Dr. Pradip K. Banerjee //
Source: https://www.businesswire.com/news/home/20250731315741/en/Instem-achieves-a-major-milestone-acquires-all-shares-of-Xybion-from-Banerjee-Group-LLC-controlled-by-Dr.-Pradip-K.-Banerjee